3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
38
Neoplasm Metastasis
16
Leukemia, Myeloid, Acute
13
Skin Neoplasms
10
Kidney Neoplasms
10
Leukemia
9
Carcinoma, Renal Cell
9
Neoplasms
7
Ovarian Neoplasms
6
Breast Neoplasms
6
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic Syndromes
4
Congenital Abnormalities
4
Neuroblastoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Recurrence
2
Papillomavirus Infections
2
Pancreatic Neoplasms
2
Lymphoma, Mantle-Cell
2
Hodgkin Disease
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms, Male
2
Waldenstrom Macroglobulinemia
1
Interventions
Carboplatin
6
Paclitaxel
5
Taxes
3
Docetaxel
3
Cisplatin
3
Gemcitabine
2
Erlotinib Hydrochloride
2
Drug Therapy
2
Bevacizumab
2
talimogene laherparepvec
1
saracatinib
1
romidepsin
1
rilotumumab
1
ganitumab
1
Zoledronic Acid
1
Vinorelbine
1
Tyrosine Kinase Inhibitors
1
Therapeutics
1
Talc
1
Surveys and Questionnaires
1
Spectrum Analysis
1
Sodium Chloride
1
Pemetrexed
1
Nivolumab
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Immunohistochemistry
1
Imatinib Mesylate
1
Gefitinib
1
Fluorodeoxyglucose F18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pleural Effusion, Malignant
×
Interleukin-2
×
Clear all
No trials found.